Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Femtosecond Laser-Assisted Keratoplasty (FLAK)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by University of Michigan.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Shahzad Mian, University of Michigan
ClinicalTrials.gov Identifier:
NCT01695811
First received: September 27, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
  Purpose

The purpose of this study will be to determine optimal surgical technique for performing FLAK including laser parameters, keratoplasty shape and suture technique in order to standardize surgical technique and to collect safety and efficacy data. This will be compared to data of patients with full thickness PKP to measure visual outcomes, refraction, astigmatism, surgical methods and wound healing.


Condition
Keratoconus

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Femtosecond Laser-Assisted Keratoplasty

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Enrollment: 24
Study Start Date: November 2007
Estimated Study Completion Date: December 2013
Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
FLAK
FLAK
PKP
Retrospective

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

subjects indicated for corneal transplant surgery

Criteria

Inclusion Criteria:

  1. Corneal opacification.
  2. Reduced ETDRS-measured, best corrected, distance visual acuity to 20/40 or worse.
  3. Ability to participate in follow-up visits..

Exclusion Criteria:

  1. Corneal opacification adequately dense to obscure visualization of iris.
  2. ETDRS-measured, best-corrected, distance visual acuity of 20/30 or better.
  3. Corneal thickness greater than 1200 µm at the 9 mm peripheral zone.
  4. Severe corneal thinning including descemetocoele with impending corneal rupture.
  5. Prior PKP or incisional surgery that may provide a potential space into which the gas produced by the procedure can escape.
  6. Poor visual potential in the non-study eye (VA of 20/100 or less, without potential for improvement by the examining ophthalmologist's judgment).
  7. History of glaucoma, including steroid response rise in intraocular pressure.
  8. Active intraocular inflammation or infection.
  9. Age 18 or younger (consideration will be given to an upper age limit).
  10. Unable to return for scheduled follow-up examinations.
  11. Other medical condition(s) that will likely prevent long term follow-up.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Shahzad Mian, Professor, Department of Ophthalmology, University of Michigan
ClinicalTrials.gov Identifier: NCT01695811     History of Changes
Other Study ID Numbers: FLAK-15615
Study First Received: September 27, 2012
Last Updated: September 27, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Michigan:
Keratoconus, PKP, femtosecond laser assisted keratoplasty

Additional relevant MeSH terms:
Keratoconus
Corneal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on November 25, 2014